Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type

CF INDUS HLDGS   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2024202320222021202020192018201720162015
Period End Date12/31/202412/31/202312/31/202212/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/2015
Sales5,936.006,631.0011,186.006,538.004,124.004,590.004,429.004,130.003,685.004,308.30
Total Revenues5,936.006,631.0011,186.006,538.004,124.004,590.004,429.004,130.003,685.004,308.30
Cost of sales3,880.004,086.005,325.004,151.003,323.003,416.003,512.003,700.002,845.002,761.20
Gross Profit2,056.002,545.005,861.002,387.00801.001,174.00917.00430.00840.001,547.10
Goodwill impairment--0.000.00285.00------------
Selling, general and administrative320.00289.00290.00223.00206.00239.00214.00192.00174.00169.80
Restructuring and integration costs--------------------
Transaction costs--------------0.00(179.00)(56.90)
Other operating-net10.0031.00(10.00)39.0017.0073.0027.00(18.00)(208.00)(92.30)
Acquisition and integration costs(4.00)(39.00)----------------
Equity in earnings of operating affiliates4.00(8.00)94.0047.0011.00(5.00)36.009.00(145.00)(35.00)
Gain on sale of phosphate business--------------------
Long-lived and intangible asset impairment0.000.00(239.00)(236.00)------------
U.K. operations restructuring0.00(10.00)(19.00)--------------
Total other operating costs and expenses314.00307.00558.00705.00189.00166.00187.00210.00--319.00
Operating Income (Loss)1,746.002,230.005,397.001,729.00623.001,003.00766.00229.00134.001,193.10
Interest expense121.00150.00344.00184.00179.00237.00241.00315.00200.00133.20
Minority interest--------------------
Interest income123.00158.0065.001.0018.0020.0013.0012.005.001.60
Income (Loss) on extinguishment of debt0.000.00(8.00)(19.00)0.00(21.00)--(53.00)(167.00)--
Other non-operating-net14.0010.00(15.00)16.001.007.009.002.002.00(3.90)
Pre-Tax Income - Domestic--------------(186.00)(43.00)1,030.40
Non-U.S--------------61.00(183.00)27.20
Earnings (loss) before income taxes1,762.002,248.005,095.001,543.00463.00772.00547.00(125.00)(226.00)1,057.60
Income tax (benefit) provision285.00410.001,158.00283.0031.00126.00119.00(575.00)(68.00)395.80
Current - Federal312.00271.00702.00394.00106.004.00--(43.00)(795.00)258.10
Deferred - Federal(89.00)108.00(102.00)(137.00)(76.00)112.00--(44.00)761.0076.40
Current - foreign42.00(26.00)395.0030.006.0021.00--19.0011.0020.10
Current - State46.0084.00168.0055.00(7.00)(48.00)--(6.00)(23.00)38.50
Deferred - foreign3.00(5.00)(18.00)(50.00)4.000.00--(3.00)(1.00)(13.30)
Deferred - state(29.00)(22.00)13.00(9.00)(2.00)37.00--(7.00)(21.00)16.00
Less: Valuation allowance--------------------
Equity in earnings (loss) of unconsolidated subsidiaries--------------0.00--72.30
Earnings (loss) before cumulative effect of a change in accounting principle--------------------
Cumulative effect of a change in accounting principle-net of taxes--------------------
Net Earnings1,477.001,838.003,937.001,260.00432.00646.00428.00450.00(158.00)734.10
Less: Net earnings attributable to the noncontrolling interest259.00313.00591.00343.00115.00153.00138.0092.00119.0034.20
Net Earnings (Loss) available to common shareholders1,218.001,525.003,346.00917.00317.00493.00290.00358.00(277.00)699.90
Basic net earnings (loss) per share6.757.8916.454.271.482.241.251.53(1.19)2.97
Diluted net earnings (loss) per share6.747.8716.384.241.472.231.241.53(1.19)2.96
Basic weighted average common shares outstanding180.40193.30203.30215.00214.90220.20232.60233.50233.10235.30
Diluted weighted average common shares outstanding180.70193.80204.20216.20215.20221.60233.80233.90233.10236.10